HELLP Cardiovascular Severity Index (CSI) Calculator
Clinical parameters
Enter laboratory values and blood pressure to calculate the source-defined score.
Scoring criteria in the supplied source
The score bands below are retained from the original calculator. Their clinical validity as a combined cardiovascular severity index has not been established by the sources verified for this redesign.
| Parameter | 0 points | 1 point | 2 points | 3 points |
|---|---|---|---|---|
| Platelet (×10⁹/L) | >150 | 100–150 | 50–99 | <50 |
| AST (U/L) | <70 | 70–120 | 121–200* | >200 |
| LDH (U/L) | <600 | 600–800 | 801–1000 | >1000 |
| Blood pressure (mmHg) | SBP <140 and DBP <90 | SBP 140–159 or DBP 90–99 | SBP 160–179 or DBP 100–109 | SBP ≥180 or DBP ≥110 |
*The implementation uses continuous numeric boundaries: AST 70–120 scores 1, >120–200 scores 2, and >200 scores 3. For blood pressure, the higher applicable systolic/diastolic band is used.
Clinical context and limitations
HELLP syndrome is assessed using clinical findings and laboratory evidence of hemolysis, elevated liver enzymes, and thrombocytopenia. Established classification systems include the Tennessee criteria and the Mississippi triple-class system; these are not equivalent to the CSI score implemented here.
Do not use this calculator as a standalone diagnostic, prognostic, or treatment decision tool. Interpret results alongside the patient's clinical condition, serial laboratory values, gestational/postpartum context, and current obstetric guidance.
Evidence status
The original file attributes this score to “Sibai et al. 2017,” but the exact four-variable CSI and its score bands could not be verified as a published validated instrument. Treat the combined score and its mild/moderate/severe labels as unvalidated pending confirmation of the original source.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.